Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients

被引：0
|
作者：
Ghavamzadeh, A. [1 ]
Alimogaddam, K. [1 ]
Khatami, F. [1 ]
Gaffari, F. [1 ]
Ashuri, A. [1 ]
Mousavi, A. [1 ]
Iravani, M. [1 ]
Bahar, B. [1 ]
Jahani, M. [1 ]
Khodabande, A. [1 ]
机构：
[1] Hematol Oncol & Bone Marrow Transplantat Res Ctr, Tehran, Iran
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 50 条
  • [1] Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Mousavi, S.
    Alimoghaddam, K.
    khatami, F.
    Jahani, M.
    Iravani, M.
    Bahar, B.
    Khodabandeh, A.
    Jalali, A.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S381 - S382
  • [2] Autologous haematopoietic cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Mousavi, A.
    Khatami, F.
    Jalili, M.
    Babhadiashar, N.
    Gaffari, F.
    Alimogaddam, K.
    Iravani, M.
    Bahar, B.
    Jahani, M.
    Khodabandelu, A.
    Baibordi, E.
    Gavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S314 - S314
  • [3] IV busulfan and fludarabine as conditioning regimen therapy for autologous stem cell transplantation in patients with acute non-lymphoid leukaemia
    Console, G.
    Messina, G.
    Moscato, T.
    Martino, M.
    Fedele, R.
    Massara, E.
    Princi, D.
    Monteleone, R.
    Redaelli, G.
    Irrera, G.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S91 - S91
  • [4] Busulfan-melphalan regimen in autologous stem cell transplantation for adult patients with acute myeloid leukaemia
    Tozzi, M.
    Marotta, G.
    Sammassimo, S.
    Galieni, P.
    Falciani, S.
    Bigazzi, C.
    Buonfrate, G.
    Lauria, F.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S65 - S65
  • [5] Intravenous busulfan as part of conditioning regimen in children undergoing allogeneic and autologous haematopoietic stem cell transplantation
    Gomez-Garcia, L.
    Molina, J. R.
    Rodriguez, G.
    Rodriguez-Villa, A.
    Garcia, E.
    Buenasmananas, D.
    Llamas, M. J.
    Chic, C.
    Rojas, R.
    Carmen, M.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S265 - S265
  • [6] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Song, Ga-Young
    Jung, Sung-Hoon
    Kim, Mihee
    Ahn, Seo-Yeon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Hyeong-Joon
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Moon, Joon Ho
    Yhim, Ho-Young
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S157 - S158
  • [7] Busulfan and thiotepa conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Hyeoung-Joon
    Kim, Jin Seok
    Kim, Kihyun
    Eom, Hyeon-Seok
    Yhim, Ho-Young
    Lee, Yoo Jin
    Hyun, Shin Young
    Lee, Je-Jung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 226 - 226
  • [8] Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide
    Lee, S. H.
    Cheuh, H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S139 - S139
  • [9] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    Cogle, CR
    Moreb, JS
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Reddy, VS
    Wingard, JR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
  • [10] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    张春阳
    China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 116 - 117
12345